GoLiver Therapeutics is the winner of the France 2030 “innovation in Biotherapies and Bioproduction” call for its GOCLINICALS project, dedicated to a novel stem cell-based liver therapy Press release GoLiver Therapeutics has been awarded €1.6m from France 2030 to progress its first biomedicine, developed from pluripotent stem cells, into the clinic for the treatment of severe...